These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19398463)

  • 21. Current management of the neonatal abstinence syndrome: a critical analysis of the evidence.
    Theis JG; Selby P; Ikizler Y; Koren G
    Biol Neonate; 1997; 71(6):345-56. PubMed ID: 9197336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study.
    Sutter MB; Watson H; Yonke N; Weitzen S; Leeman L
    BMC Pediatr; 2022 Jun; 22(1):345. PubMed ID: 35705944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative effectiveness of alpha-2 adrenergic agonists (clonidine-guanfacine) in the hospital detoxification of opiate addicts].
    Muga R; Tor J; Forteza-Rei J; Jacas C; Altés J; Mestre L
    Med Clin (Barc); 1990 Feb; 94(5):169-72. PubMed ID: 1969980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphine versus clonidine for neonatal abstinence syndrome.
    Bada HS; Sithisarn T; Gibson J; Garlitz K; Caldwell R; Capilouto G; Li Y; Leggas M; Breheny P
    Pediatrics; 2015 Feb; 135(2):e383-91. PubMed ID: 25624389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of clonidine and of methadone in the rapid detoxification of patients dependent on heroin.
    Camí J; de Torres S; San L; Solé A; Guerra D; Ugena B
    Clin Pharmacol Ther; 1985 Sep; 38(3):336-41. PubMed ID: 4028630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.
    Kraft WK; Adeniyi-Jones SC; Chervoneva I; Greenspan JS; Abatemarco D; Kaltenbach K; Ehrlich ME
    N Engl J Med; 2017 Jun; 376(24):2341-2348. PubMed ID: 28468518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial.
    San L; Camí J; Peri JM; Mata R; Porta M
    Br J Addict; 1990 Jan; 85(1):141-7. PubMed ID: 1968773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial.
    Brown MS; Hayes MJ; Thornton LM
    J Perinatol; 2015 Apr; 35(4):278-83. PubMed ID: 25357093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of tincture of opium compared to oral morphine for the treatment of neonatal abstinence syndrome.
    Kokotajlo S; Robinson CA; Presti A
    J Opioid Manag; 2013; 9(1):62-70. PubMed ID: 23709305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacotherapy for Neonatal Abstinence Syndrome: Choosing the Right Opioid or No Opioid at All.
    McPherson C
    Neonatal Netw; 2016; 35(5):314-20. PubMed ID: 27636696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sedatives for opiate withdrawal in newborn infants.
    Osborn DA; Jeffery HE; Cole MJ
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002053. PubMed ID: 16034870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
    Umbricht A; Hoover DR; Tucker MJ; Leslie JM; Chaisson RE; Preston KL
    Drug Alcohol Depend; 2003 Apr; 69(3):263-72. PubMed ID: 12633912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose intrathecal clonidine combined with sufentanil as analgesic drugs in abdominal gynecological surgery.
    Julião MC; Lauretti GR
    J Clin Anesth; 2000 Aug; 12(5):357-62. PubMed ID: 11025234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient Pharmacotherapy for Neonatal Abstinence Syndrome.
    Maalouf FI; Cooper WO; Slaughter JC; Dudley J; Patrick SW
    J Pediatr; 2018 Aug; 199():151-157.e1. PubMed ID: 29754866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative analgesia using a low-dose, oral-transdermal clonidine combination: lack of clinical efficacy.
    Owen MD; Fibuch EE; McQuillan R; Millington WR
    J Clin Anesth; 1997 Feb; 9(1):8-14. PubMed ID: 9051539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between gestational age and the severity of neonatal abstinence syndrome.
    Gibson KS; Stark S; Kumar D; Bailit JL
    Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
    Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
    Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral clonidine in the management of acquired opioid dependency.
    Beaulieu MJ
    Neonatal Netw; 2013; 32(6):419-24. PubMed ID: 24195803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sedatives for opiate withdrawal in newborn infants.
    Osborn DA; Jeffery HE; Cole MJ
    Cochrane Database Syst Rev; 2002; (3):CD002053. PubMed ID: 12137641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trial.
    Peltz G; Jansson LM; Adeniyi-Jones S; Cohane C; Drover D; Shafer S; Wang M; Wu M; Govindaswami B; Jegatheesan P; Argani C; Khan S; Kraft WK
    J Perinatol; 2023 Mar; 43(3):271-276. PubMed ID: 36030327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.